Recommended for at-risk children: ATAGI recommends COVID-19 vaccination for children aged 6 months to <5 years with severe immunocompromise, disability, and those who have complex and/or multiple health conditions which increase the risk of severe COVID-19. This includes conditions listed in the ATAGI recommendations and similar conditions.
Not recommended for all children: ATAGI does not currently recommend vaccination for children aged 6 months to <5 years who are not in the risk categories for severe COVID-19.
Dosing and schedule: Paediatric formulation (25mcg) Moderna COVID-19 vaccine, 2 primary doses 8 weeks apart. Children with severe immunocompromise should receive a 3rd primary dose, 8 weeks after the 2nd dose.
Availability of vaccines
Two vaccines are/will be available in Australia for prevention of monkeypox:
ACAM2000™ (2nd generation) is only available from the National Medical Stockpile on a request basis for State and Territory governments
JYNNEOS® (3rd generation) have been secured in limited supplies by the Commonwealth and some States and Territories
NSW Health is working as quickly as possible to facilitate access to JYNNEOS® vaccines
Access to vaccines
Vaccines for the prevention of monkeypox virus is being managed by NSW Health. More information about MPX vaccination hubs and/or access to vaccines will become available soon. Check our CESPHN Alerts webpage for a consolidation of monkeypox information from key organisations (NSW Heath, Dept of Health, ACON, SHIL, and more)
ATAGI has released guidance on the use of smallpox vaccine for protection against Monkeypox (MPX) virus infection.
Infectious Disease Specialist (ID specialist) 8890 5555 – for any suspected monkeypox cases, GPs must immediately contact the ID specialist before taking any samples. The ID specialist will advise on the appropriate test and clinical management of the case.
Public Health Unit (PHU) 1300 066 055 – GPs must notify any suspected cases of monkeypox to the PHU to initiate a public health investigation, contact tracing and control measures. MPX has been added to the list of notifiable diseases under the Public Health Act 2010.
NSW Sexual Health Infolink (SHIL) 1800 451 624 – SHIL provides specialist clinical support and information to health professionals who are treating clients with sexual health issues, including monkeypox infections.
Monkeypox support – Key contacts for patients
NSW Sexual Health Infolink (SHIL) 1800 451 624 – SHIL provides sexual health information and referral services to community members, including monkeypox information and advice.
ACON9206 2000 – provides monkeypox information for LGBTQ+ communities in NSW. ACON is working with health authorities to facilitate vaccine access as quickly as possible, particularly for higher risk groups in LGBTQ+ communities.
New AIR code for smallpox vaccine
There have been 3 smallpox vaccines added to the list of AIR vaccine code formats that are able to be recorded on the Australian Immunisation Register. Smallpox vaccines given overseas can be recorded either using the specific vaccine code or the generic smallpox code.
GP knowledge gaps with Zostavax use in the immunocompromised
New research has found notable knowledge gaps continue to exist among Australian general practitioners (GPs) regarding live attenuated zoster vaccination of immunocompromised people.
While the vaccine is safe, its use is contraindicated in severely immunocompromised people because the virus from the vaccine can cause serious disseminated infection. There have been three Zostavax-related deaths in immunocompromised people between 2017 and 2020 in Australia.
The research, led by NCIRS, used an online survey to assess the knowledge of GPs regarding Zostavax. GPs were asked to respond to five clinical scenarios testing their knowledge of Zostavax contraindications, and the proportion of correct answers ranged from 25% to 82% across all scenarios.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…